Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 2—February 2012

Association of Human Bocavirus 1 Infection with Respiratory Disease in Childhood Follow-up Study, Finland

Mira Meriluoto, Lea Hedman, Laura Tanner, Ville Simell, Marjaana Mäkinen, Satu Simell, Juha Mykkänen, Jan Korpelainen, Olli Ruuskanen, Jorma Ilonen, Mikael Knip, Olli Simell, Klaus Hedman, and Maria Söderlund-VenermoComments to Author 
Author affiliations: University of Helsinki, Helsinki, Finland (M. Meriluoto, L. Hedman, M. Knip, K. Hedman, M. Söderlund-Venermo); Haartman Institute, Helsinki (M. Meriluoto, L. Hedman, K. Hedman, M. Söderlund-Venermo); Helsinki University Central Hospital, Helsinki (L. Hedman, M. Knip, K. Hedman); University of Turku, Turku, Finland (L. Tanner, V. Simell, M. Mäkinen, S. Simell, J. Mykkänen, J. Korpelainen, O. Ruuskanen, J. Ilonen, O. Simell); University of Eastern Finland, Kuopio, Finland (J. Ilonen); Tampere University Hospital, Tampere, Finland (M. Knip); Folkhälsan Research Center, Helsinki (M. Knip)

Main Article

Table 1

Human bocavirus IgG results from 109 constitutionally healthy children, Finland

Result* No. (%) Age, y
Mean Median Range
Seroconversion 102 (94) 2.30 2.08 0.31–6.00
Secondary response† 38 (35) 4.79 4.77 0.73–9.79
Reconversion 7 (6) 6.29 7.07 1.59–8.15

*Maternal antibodies, i.e., low-level (vanishing) IgG, were detected in 35/88 children from whom serum was taken ≤6 mo. of age. Seven children were IgG positive from birth, and their maternal antibodies were not seen to disappear before induction of their own immunity. For 73, the IgG level remained high; for 26, the IgG level decreased with time; and 10 underwent IgG reversion.
>4-fold increase in, or reconversion of, high avidity IgG (2 children had 2 and 2 other children had 3 secondary immune responses).

Main Article

Page created: January 17, 2012
Page updated: January 17, 2012
Page reviewed: January 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.